5-hydroxy Imidacloprid

Scintel Pharmachem Private Limited is a pioneering presence in the healthcare industry, specializing in pharmaceuticals and specialty chemicals founded by Abhijit Padhye and his dedicated team, the company boasts the support of scientific experts and seasoned chemistry professionals with over 24 years of experience in API development and manufacturing. Scintel's primary focus is on the creation, development, and manufacturing of Low Volume High-Value APIs, including High Potent APIs, bulk drug APIs, Specialty custom chemicals, and impurities.

We've established a state-of-the-art R&D facility in Hyderabad, Telangana, India, and have secured strategic

partnerships with renowned API manufacturers known for their cGMP/GLP compliance and approvals from Indian FDA and USFDA across Maharashtra, Karnataka, and Telangana.

Our product portfolio encompasses the production and distribution of APIs, Intermediates, and impurities to cater to innovators, formulators, and generic Pharmaceutical companies in both domestic and international markets, including regulated markets. Scintel has positioned itself to serve as a comprehensive solution for all your needs in synthetic pharmaceutical substances and high-value

specialty chemicals. In addition, we've broadened our services to encompass CRAMS, CDMO, custom synthesis, impurities and project management unlocking significant global potential.

Prime Business Focus Areas

-Bulk Drug APIs

-High Potent APIs (Prostaglandins, Oncology, Hormones , Peptides )

-Intermediates and Specialty Chemicals (CDMO)

-Impurities